ANEB - Financial Reports List - Anebulo Pharmaceuticals, Inc. - IntrinsicAlpha

Anebulo Pharmaceuticals, Inc. ANEB

Healthcare - Biotechnology - NASDAQ - US

$ 0.953

-5.94 %

$ 39.2 M

Market Cap

-3.28

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q2	8-K	2024-12-31	0.00%	9.36%	6.24%
Quarterly Report	Q1	8-K	2024-09-30	0.00%	11.29%	5.17%
Quarterly Report	Q4	8-K	2024-06-30	0.00%	45.91%	46.26%
Annual Report	FY	10-K	2024-06-30	0.00%	30.09%	29.49%
Quarterly Report	Q3	8-K	2024-03-31	0.00%	40.90%	41.89%
Quarterly Report	Q2	8-K	2023-12-31	0.00%	29.25%	27.61%
Quarterly Report	Q1	8-K	2023-09-30	0.00%	5.02%	2.62%
Quarterly Report	Q4	8-K	2023-06-30	0.00%	-7.66%	-7.26%
Annual Report	FY	10-K	2023-06-30	0.00%	-72.21%	-72.50%
Quarterly Report	Q3	8-K	2023-03-31	0.00%	-49.36%	-52.37%

1